Adicet Bio
ACET
#10726
Rank
โ‚ฌ18.26 M
Marketcap
1,95ย โ‚ฌ
Share price
-13.01%
Change (1 day)
287.96%
Change (1 year)

Adicet Bio (ACET) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ25.55 Million

According to Adicet Bio's latest financial reports the company's total liabilities are โ‚ฌ25.55 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adicet Bio - Total liabilities on balance sheet (from 2019 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ28.21 M-12.64%
2024-12-31โ‚ฌ32.29 M-3.81%
2023-12-31โ‚ฌ33.57 M-6.08%
2022-12-31โ‚ฌ35.75 M13.08%
2021-12-31โ‚ฌ31.61 M-11.63%
2020-12-31โ‚ฌ35.77 M-71.76%
2019-12-31โ‚ฌ0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚ฌ72.54 B 283,848.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ105.41 B 412,483.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ80.05 B 313,222.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ29.26 B 114,428.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
โ‚ฌ0.40 B 1,499.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
โ‚ฌ1.34 B 5,146.61%๐Ÿ‡บ๐Ÿ‡ธ USA